ArticleFrontiers in immunology2024

Safety assessment of anti-B cell maturation antigen chimeric antigen receptor T cell therapy: a real-world study based on the FDA adverse event reporting system database.

Wei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.